Neural stem cell-mediated enzyme/prodrug therapy for glioma: Preclinical studies

Science Translational Medicine

Volumn 5, Issue 184, 2013, Pages

  Aboody, Karen S ^a   Najbauer, Joseph ^a   Metz, Marianne Z ^a   D'Apuzzo, Massimo ^a   Gutova, Margarita ^a   Annala, Alexander J ^a   Synold, Timothy W ^a   Couture, Larry A ^a   Blanchard, Suzette ^a   Moats, Rex A ^b   Garcia, Elizabeth ^a   Aramburo, Soraya ^a   Valenzuela, Valerie V ^a   Frank, Richard T ^a   Barish, Michael E ^a   Brown, Christine E ^a   Kim, Seung U ^c   Badie, Behnam ^a   Portnow, Jana ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; DEXAMETHASONE; FLUCYTOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME PRODRUG THERAPY; FEMALE; FETUS; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEURAL STEM CELL MEDIATED ENZYME PRODRUG THERAPY; NONHUMAN; PRIORITY JOURNAL; TROPISM; TUMOR VOLUME;

ANIMALS; CELL LINE; CYTOSINE DEAMINASE; FEMALE; FLOW CYTOMETRY; FLUCYTOSINE; FLUOROURACIL; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NEURAL STEM CELLS; PRODRUGS;

EID: 84878335302     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005365     Document Type: Article

References (47)

1. P. Y. Wen, S. Kesari, Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507 (2008).
2. M. Westphal, K. Lamszus, The neurobiology of gliomas: From cell biology to the development of therapeutic approaches. Nat. Rev. Neurosci. 12, 495-508 (2011).
3. J. A. Schwartzbaum, J. L. Fisher, K. D. Aldape, M. Wrensch, Epidemiology and molecular pathology of glioma. Nat. Clin. Pract. Neurol. 2, 494-503 (2006).
4. R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer, S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer, R. O. Mirimanoff; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005).
5. R. Stupp, M. E. Hegi, W. P. Mason, M. J. van den Bent, M. J. Taphoorn, R. C. Janzer, S. K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A. A. Brandes, J. Gijtenbeek, C. Marosi, C. J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. G. Cairncross, R. O. Mirimanoff, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466 (2009).
6. E. A. Neuwelt, B. Bauer, C. Fahlke, G. Fricker, C. Iadecola, D. Janigro, L. Leybaert, Z. Molnár, M. E. O' Donnell, J. T. Povlishock, N. R. Saunders, F. Sharp, D. Stanimirovic, R. J. Watts, L. R. Drewes, Engaging neuroscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 12, 169-182 (2011).
7. A. I. Minchinton, I. F. Tannock, Drug penetration in solid tumours. Nat. Rev. Cancer 6, 583-592 (2006).
8. A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen, Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence. Neurology 70, 779-787 (2008).
9. K. S. Aboody, J. Najbauer, M. K. Danks, Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15, 739-752 (2008).
10. R. T. Frank, J. Najbauer, K. S. Aboody, Concise review: Stem cells as an emerging platform for antibody therapy of cancer. Stem Cells 28, 2084-2087 (2010).
11. A. U. Ahmed, B. Thaci, N. G. Alexiades, Y. Han, S. Qian, F. Liu, I. V. Balyasnikova, I. Y. Ulasov, K. S. Aboody, M. S. Lesniak, Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol. Ther. 19, 1714-1726 (2011).
12. R. T. Frank, M. Edmiston, S. E. Kendall, J. Najbauer, C. W. Cheung, T. Kassa, M. Z. Metz, S. U. Kim, C. A. Glackin, A. M. Wu, P. J. Yazaki, K. S. Aboody, Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS One 4, e8314 (2009).
13. K. S. Aboody, A. Brown, N. G. Rainov, K. A. Bower, S. Liu, W. Yang, J. E. Small, U. Herrlinger, V. Ourednik, P. M. Black, X. O. Breakefield, E. Y. Snyder, Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci. U.S.A. 97, 12846-12851 (2000).
14. J. Najbauer, M. K. Danks, N. O. Schmidt, S. U. Kim, K. S. Aboody, in Progress in Gene Therapy, Autologous and Cancer Stem Cell Gene Therapy, R. Bertolotti, K. Ozawa, Eds. (World Scientific, Singapore, 2008), vol. 3, pp. 335-372.
15. S. K. Kim, T. G. Cargioli, M. Machluf, W. Yang, Y. Sun, R. Al-Hashem, S. U. Kim, P. M. Black, R. S. Carroll, PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin. Cancer Res. 11, 5965-5970 (2005).
16. S. U. Kim, Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev. 7, 130-140 (2011).
17. M. Gutova, G. M. Shackleford, V. Khankaldyyan, K. A. Herrmann, X. H. Shi, K. Mittelholtz, Y. Abramyants, M. S. Blanchard, S. U. Kim, A. J. Annala, J. Najbauer, T. W. Synold, M. D'Apuzzo, M. E. Barish, R. A. Moats, K. S. Aboody, Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mousemodel of intracerebellarmedulloblastoma. Gene Ther. 20, 143-150 (2013).
18. S. K. Kim, S. U. Kim, I. H. Park, J. H. Bang, K. S. Aboody, K. C. Wang, B. K. Cho, M. Kim, L. G. Menon, P. M. Black, R. S. Carroll, Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res. 12, 5550-5556 (2006).
19. S. Shimato, A. Natsume, H. Takeuchi, T. Wakabayashi, M. Fujii, M. Ito, S. Ito, I. H. Park, J. H. Bang, S. U. Kim, J. Yoshida, Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther. 14, 1132-1142 (2007).
20. K. S. Aboody, J. Najbauer, N. O. Schmidt, W. Yang, J. K. Wu, Y. Zhuge, W. Przylecki, R. Carroll, P. M. Black, G. Perides, Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol. 8, 119-126 (2006).
21. D. Zhao, J. Najbauer, A. J. Annala, E. Garcia, M. Z. Metz, M. Gutova, M. D. Polewski, M. Gilchrist, C. A. Glackin, S. U. Kim, K. S. Aboody, Human neural stem cell tropism to metastatic breast cancer. Stem Cells 30, 314-325 (2012).
22. M. K. Danks, K. J. Yoon, R. A. Bush, J. S. Remack, M. Wierdl, L. Tsurkan, S. U. Kim, E. Garcia, M. Z. Metz, J. Najbauer, P. M. Potter, K. S. Aboody, Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res. 67, 22-25 (2007).
23. T. L. Sims Jr., J. B. Hamner, R. A. Bush, P. E. Fischer, S. U. Kim, K. S. Aboody, B. McCarville, M. K. Danks, A. M. Davidoff, Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. J. Pediatr. Surg. 44, 204-210 (2009).
24. H. J. Seol, J. Jin, D. H. Seong, K. M. Joo, W. Kang, H. Yang, J. Kim, C. S. Shin, Y. Kim, K. H. Kim, D. S. Kong, J. I. Lee, K. S. Aboody, H. J. Lee, S. U. Kim, D. H. Nam, Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Lett. 311, 152-159 (2011).
25. S. U. Kim, Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24, 159-171 (2004).
26. S. U. Kim, E. Nakagawa, K. Hatori, A. Nagai, M. A. Lee, J. H. Bang, Production of immortalized human neural crest stem cells. Methods Mol. Biol. 198, 55-65 (2002).
27. S. U. Kim, Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Dev. 29, 193-201 (2007).
28. S. U. Kim, A. Nagai, E. Nakagawa, H. B. Choi, J. H. Bang, H. J. Lee, M. A. Lee, Y. B. Lee, I. H. Park, Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol. Biol. 438, 103-121 (2008).
29. B. E. Huber, E. A. Austin, C. A. Richards, S. T. Davis, S. S. Good, Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. U.S.A. 91, 8302-8306 (1994).
30. C. E. Brown, R. Starr, B. Aguilar, A. F. Shami, C. Martinez, M. D'Apuzzo, M. E. Barish, S. J. Forman, M. C. Jensen, Stem-like tumor-initiating cells isolated from IL13Ra2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T cells. Clin. Cancer Res. 18, 2199-2209 (2012).
31. D. N. Louis, Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1, 97-117 (2006).
32. D. Zhao, J. Najbauer, E. Garcia, M. Z. Metz, M. Gutova, C. A. Glackin, S. U. Kim, K. S. Aboody, Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol. Cancer Res. 6, 1819-1829 (2008).
33. D. Lin, J. Najbauer, P. M. Salvaterra, A. N. Mamelak, M. E. Barish, E. Garcia, M. Z. Metz, S. E. Kendall, M. Bowers, B. Kateb, S. U. Kim, M. Johnson, K. S. Aboody, Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. Neuroimage 37 (Suppl. 1), S18-S26 (2007).
34. S. E. Kendall, J. Najbauer, H. F. Johnston, M. Z. Metz, S. Li, M. Bowers, E. Garcia, S. U. Kim, M. E. Barish, K. S. Aboody, C. A. Glackin, Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells 26, 1575-1586 (2008).
35. E. M. Lee, J. Y. Kim, B. R. Cho, W. K. Chung, B. W. Yoon, S. U. Kim, B. C. Lee, W. S. Hwang, S. Y. Moon, J. S. Lee, C. Ahn, Down-regulation of MHC class I expression in human neuronal stem cells using viral stealth mechanism. Biochem. Biophys. Res. Commun. 326, 825-835 (2005).
36. H. J. Lee, I. H. Park, H. J. Kim, S. U. Kim, Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. Gene Ther. 16, 1066-1076 (2009).
37. K. Aboody, A. Capela, N. Niazi, J. H. Stern, S. Temple, Translating stem cell studies to the clinic for CNS repair: Current state of the art and the need for a Rosetta stone. Neuron 70, 597-613 (2011).
38. A. U. Ahmed, I. V. Ulasov, R. W. Mercer, M. S. Lesniak, Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors. Methods Mol. Biol. 797, 97-109 (2012).
39. S. U. Kim, J. de Vellis, Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 87, 2183-2200 (2009).
40. T. Yasuhara, N. Matsukawa, K. Hara, G. Yu, L. Xu, M. Maki, S. U. Kim, C. V. Borlongan, Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J. Neurosci. 26, 12497-12511 (2006).
41. S. W. Jeong, K. Chu, K. H. Jung, S. U. Kim, M. Kim, J. K. Roh, Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34, 2258-2263 (2003).
42. J. K. Ryu, H. B. Choi, K. Hatori, R. L. Heisel, S. L. Pelech, J. G. McLarnon, S. U. Kim, Adenosine triphosphate induces proliferation of human neural stem cells: Role of calcium and p70 ribosomal protein S6 kinase. J. Neurosci. Res. 72, 352-362 (2003).
43. M. Niewald, C. Berdel, J. Fleckenstein, N. Licht, R. Ketter, C. Rübe, Toxicity after radiochemotherapy for glioblastoma using temozolomide - A retrospective evaluation. Radiat. Oncol. 6, 141 (2011).
44. Y. R. Lawrence, M. Wang, A. P. Dicker, D. Andrews, W. J. Curran Jr., J. M. Michalski, L. Souhami, W. K. Yung, M. Mehta, Early toxicity predicts long-term survival in high-grade glioma. Br. J. Cancer 104, 1365-1371 (2011).
45. L. A. Christie, M. M. Acharya, V. K. Parihar, A. Nguyen, V. Martirosian, C. L. Limoli, Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin. Cancer Res. 18, 1954-1965 (2012).
46. K. J. Yoon, M. K. Danks, S. T. Ragsdale, M. B. Valentine, V. A. Valentine, Translocations of 17q21∼qter in neuroblastoma cell lines infrequently include the topoisomerase IIα gene. Cancer Genet. Cytogenet. 167, 92-94 (2006).
47. R Foundation for Statistical Computing, A Language and Environment for Statistical Computing (R Development Core Team, Vienna, Austria, 2011); http://www.R-project.org. stm.sciencemag.org.